| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.08 |